A Rare Cutaneous Complication of Insulin in a Patient With Type 2 Diabetes That Developed Foot Necrosis at the Injection Site: A Result of Inadequate Patient Education

Tosun Haci Bayram, Gumustas Seyitali, Agir Ismail, Uludag Abuzer, Serbest Sancar


Cutaneous complications of insulin became rare due to the introduction of highly purified recombinant human insulin preparations. We reported a case of a 63-year-old Anatolian man with type 2 diabetes mellitus that developed foot necrosis at the injection sites after local administration of analog recombinant mixed insulin to dorsal aspect of the foot due to foot pain. This case is rare and very interesting. The education of patients who use insulin is crucial to prevent skin-related complications of insulin therapy. So education is a part of treatment for patient with diabetes.

J Endocrinol Metab. 2014;4(1-2):36-38
doi: http://dx.doi.org/10.14740/jem210w


Diabetic foot; Diabetes; Insulin therapy; Patient education

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.